BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27498138)

  • 21. Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis.
    Ozturk K; Onal MS; Efiloglu O; Nikerel E; Yildirim A; Telci D
    Gene; 2020 Jun; 742():144589. PubMed ID: 32179174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population.
    Kotarac N; Dobrijevic Z; Matijasevic S; Savic-Pavicevic D; Brajuskovic G
    Pathol Oncol Res; 2020 Oct; 26(4):2409-2423. PubMed ID: 32556890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
    Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
    Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
    Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
    Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
    Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
    Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism rs3742330 in microRNA Biogenesis Gene
    Kondkar AA; Azad TA; Sultan T; Radhakrishnan R; Osman EA; Almobarak FA; Lobo GP; Al-Obeidan SA
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
    Avgeris M; Stravodimos K; Scorilas A
    Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patients.
    Reyes-Hernández OD; Vega L; Jiménez-Ríos MA; Martínez-Cervera PF; Lugo-García JA; Hernández-Cadena L; Ostrosky-Wegman P; Orozco L; Elizondo G
    PLoS One; 2014; 9(6):e99974. PubMed ID: 24924803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
    Kim S; Shin C; Jee SH
    Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants in microRNA machinery genes are associated [corrected] with idiopathic recurrent pregnancy loss risk.
    Jung YW; Jeon YJ; Rah H; Kim JH; Shin JE; Choi DH; Cha SH; Kim NK
    PLoS One; 2014; 9(4):e95803. PubMed ID: 24769857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
    Zambra FM; Biolchi V; Brum IS; Chies JA
    Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DROSHA rs10719 and DICER1 rs3742330 polymorphisms in endometriosis and different diseases: Case-control and review studies.
    Cardoso JV; Medeiros R; Dias F; Costa IA; Ferrari R; Berardo PT; Perini JA
    Exp Mol Pathol; 2021 Apr; 119():104616. PubMed ID: 33535080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of microRNA processing machinery gene (DROSHA, DICER1, RAN, and XPO5) variants association with end-stage renal disease.
    Fawzy MS; Abu AlSel BT; Toraih EA
    J Clin Lab Anal; 2020 Dec; 34(12):e23520. PubMed ID: 32770606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nucleotide variants in microRNA biosynthesis genes in Mexican individuals.
    Juárez-Luis J; Canseco-Ocaña M; Cid-Soto MA; Castro-Martínez XH; Martínez-Hernández A; Orozco L; Hernández-Zavala A; Córdova EJ
    Front Genet; 2023; 14():1022912. PubMed ID: 36968598
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ.
    Menezes RDS; Dornas MC; Campos CFF; Rodeiro DB; Carrerette FB; Oliveira RV; de Souza BA; Alves de Souza Carvalho G; Brito IAA; Silva DA; Damião R; Porto LC
    Prostate; 2024 Feb; 84(2):166-176. PubMed ID: 37839045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.